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The renin gene and aldosterone-producing adenomas. Approximately
one half of the aldosterone-producing adenomas (APA) removed from
patients with primary aldosteronism in the Hypertension Unit at Green-
slopes Hospital belong to a subgroup in which aldosterone levels are
responsive to the renin-angiotensin system (angiotensin-responsive APA;
AII-R-APA), unlike classical APAs in which aldosterone is unresponsive
(All-U-APA). Renin mRNA levels in AII-R-APA were elevated when
compared with those in AlI-U-APA or normal adrenal cortices. Renin
mRNA levels in some adrenal cortices surrounding AII-R-APA (but never
in AII-U-APA) were raised, suggesting that a genetic defect is not
confined to the tumor. Renin gene RFLP analysis in peripheral blood
DNA revealed a significant difference in allelic frequencies between
patients with AII-R-APA and AII-U-APA, suggesting an association
between an alteration in the renin gene and aldosterone responsiveness to
the renin-angiotensin system in patients with APAs.
In 1987 [1, 2] we described a subgroup of patients with
aldosterone-producing adenomas (APAs) in whom aldosterone
levels responded (>50% increase over basal) to upright posture
and angiotensin infusion (angiotensin-responsive APAs; AII-R-
APAs), as is seen in patients with bilateral adrenal hyperplasia, in
contrast to the lack of aldosterone responsiveness seen in patients
with classical angiotensin unresponsive APAs (AII-U-APAs). The
Hypertension Unit at Greenslopes Hospital has, since 1970,
diagnosed and treated more than 280 patients with primaly
aldosteronism. Approximately one half of the 110 patients with
primaly aldosteronism due to APAs since 1982 were angiotensin-
responsive.
Since, (1) high concentrations of renin and plasma renin activity
have been detected in APAs [3, 4], (2) APAs concomitantly
release renin, angiotensin II and aldosterone [5, 6], and (3)
coexpression of mRNA for renin, angiotensinogen and ACE has
been observed in some but not all APAs [7, 8], we reasoned that
differing in vivo responses to the renin-angiotensin system may
arise from differing levels of expression of renin mRNA in the
tumors.
We recently reported that renin mRNA is expressed in larger
amounts in angiotensin-responsive (AII-R-APAs) than in angio-
tensin-unresponsive APAs (AII-U-APAs) or normal adrenal cor-
tices [9, 10].
Since the adrenal cortex surrounding the APA is often histo-
logically hyperplastic, or even frankly nodular [11], the expression
of renin mRNA in such tissue is of great interest. However, since
the aldosterone response to angiotensin is very much reduced 7 to
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10 days after unilateral adrenalectomy [12], most of the respon-
siveness observed preoperatively must have resided in the tumor.
However, if nodules and adenomas arise from the non-tumorous
cortex, their subsequent biochemical behavior may reflect the
potential of the tissue from which they arise. We therefore
examined renin mRNA expression in paired samples of APA and
surrounding adrenal cortex. In vivo responsiveness of adrenal
cortical tissue to the renin-angiotensin system was determined by
measuring plasma aldosterone levels before and after angiotensin
II infusion (2 ng/kg/min for 60 mm). Unilateral APAs were
lateralized by adrenal vein sampling in nine patients with AII-R-
APAs (46 to 78 years, 2 females) and seven patients with
AII-U-APAs (48 to 69 years, 5 females) and subsequently the
adrenal containing an adenoma on that side was removed. The
adrenals from four patients who had undergone radical nephrec-
tomy for renal cancer, and one patient who had undergone
adrenalectomy for a non-functioning adrenal cyst, were also
examined. Expression of renin mRNA was examined as previously
described [9]. When patients with AII-R-APAs were compared
with those with AII-U-APAs: (i) they were slightly but not
significantly older; (ii) the usual female to male preponderance of
AII-U-APAs was reversed, consistent with our previous observa-
tions of a gender difference in the two groups, (iii) they had more
right (67%) than left-sided (33%) APAs, as did patients with
AII-U-APAs (57% and 43%); (iv) they had slightly but not
significantly smaller tumors than patients with AII-U-APAs; and
(v) as previously reported [13], AII-R-APAs consisted of 0 to 20%
zona fasciculata type cells while AII-U-APAs consisted of 50 to
100% zona fasciculata type cells. The surrounding adrenal corti-
ces from both types of tumors frequently showed mild to moder-
ate hyperplasia of the zona glomerulosa. Aldosterone responses
to angiotensin infusion after overnight recumbency were 64 20
(sEM) to 57 17 ng/100 ml for AII-U-APAs and 27 6 to 66
13 ng/100 ml for AII-R-APAs.
In seven AII-U-APA, renin mRNA expression (renin cDNA as
a percentage of internal standard) was similar to (in 2) or lower
than (in 5) that observed in five normal adrenals (Fig. 1).
Similarly, renin mRNA from surrounding cortex was similar to or
lower than that observed in normal adrenals. In contrast, in
AII-R-APAs, renin mRNA expression was higher than in normal
adrenals in eight of nine, and lower than normal in one. In
surrounding adrenal cortical tissue, renin mRNA was higher than
in normal adrenals in four of nine, and normal or lower than
normal in the remaining five.
In summary, renin mRNA was expressed in greater amounts
than in normal adrenal cortices in most AII-R-APAs, but in no
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tension. Furthermore, an association between blood pressure and
an RFLP located in Intron A of the renin gene has been reported
by Barley and coworkers [24] in Afro-Caribbeans. As well, Rapp
and coworkers [25, 26] found in SHR that an RFLP associated
with a 1.2 kb insertion in Intron A of the renin gene differentiated
salt sensitive from salt resistant rats. The RFLP cosegregated with
a rise in blood pressure in F2 crosses of salt-resistant and
salt-sensitive rats, and they suggested that allelic variation in the
renin gene may affect renin gene expression and could account for
low plasma, renal and adrenal renin, and lack of adrenal renin
responsiveness to a sodium deficient diet that characterize salt-
sensitive SHR. Rather than also studying the varied and ill-
defined phenotype of essential hypertension, we examined the
relationship between a defined phenotype (aldosterone respon-
siveness to the renin-angiotensin system in hypertensive patients
with primaly aldosteronism) and allelic frequencies of renin gene
RFLPs.
The Taq I RFLP is located in the 5' untranslated region of the
renin gene [18], 4.5 kb upstream from Exon 1, the Bgl I RFLP in
Intron A [18], 1 kb from Exon 1, the Hinf I RFLP is also in Intron
A [20] (precise location undetermined) and the Hind III RFLP in
_______________________________________________________ the 3' untranslated region [18]. We found a significant association
________ ________
between the Bgl I, Taq I and Hinf I renin RFLPs and aldosterone
responsiveness to the renin-angiotensin system in patients with
AII-U-APA and AII-R-APA. This suggests that these RFLP sites
are in linkage disequilibrium with a site in the region of Exon
1/Intron A which is associated with aldosterone responsiveness.
This represents possibly the first described association of allelic
variation in the renin gene with a "cause" of human hypertension,
namely aldosterone-producing adenomas.
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Fig. 1. Renin mRNA levels, expressed as cDNA measured as a percentage of
internal standard in tumor tissue and sun-ounding cortex in patients with
angiotensin-responsive (AII-R) and angiotensin unresponsive (All-U) aldo-
sterone-producing adenomas (APA) and in normal adrenal cortices.
Table 1. Allelic frequencies for four renin gene restriction fragment
length polymorphisms in patients with AII-U-APA and AII-R-APA
Enzymes A a A a P
Taq I 21 79 7 93 4.0 <0.05
Hinf I 52 48 21 79 11.1 <0.001
Bgl I 57 43 83 17 9.2 <0.002
Hind III 69 31 60 40 0.9 NS
Reprint requests to Dr. Shelley A. Kiemm, Hypertension Unit, Greenslopes
Hospital, Greenslopes, Brisbane, Australia, 4120.
NS is not significant.
AII-U-APAs. Renin mRNA expression was always similar to or
lower than that observed in normal adrenal cortices in adrenal
cortical tissue surrounding AII-U-APA. In contrast, the non-
tumorous adrenal cortical tissue from approximately one half the
adrenals containing AII-R-APAs showed over-expression of
mRNA for renin. These studies provide evidence for a genetic
alteration shared by most angiotensin-responsive APAs and some
adrenal cortices from which they arose.
These results prompted us to examine whether an alteration in
the constitutive renin gene may account for differing renin gene
expression in these tumor subgroups. We examined allelic fre-
quencies of four renin gene restriction fragment length polymor-
phisms (RFLPs; Bgl I, Taq I, Hinf I, HindlIl; [14, 15]) in genomic
DNA extracted from peripheral blood leukocytes from 30 patients
with AII-R-APAs (38 to 82 years, 7 females) and 29 patients with
AII-U-APAs (27 to 69 years, 18 females). Mean aldosterone
responses to angiotensin infusion were 47 6 to 47 5 ng/100 ml
in AII-U-APAs and 28 5 to 63 10 ng/100 ml in AII-R-APAs.
Chi squared analysis showed that with the Taq I, Hinf I and Bgl
I RFLPS, but not the Hind III RFLP, allelic frequencies were
significantly different between the two groups (Table 1).
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